Clinical InvestigationElectrophysiologyElectrocardiographic predictors of atrial fibrillation
Section snippets
Study design
The Palo Alto Veterans Affairs Health Care System uses a computerized ECG system (GE Marquette) to collect, store, and analyze ECGs. This system has been validated by both the US Food and Drug Administration and the European Community and is widely used across the world. The current study involved the retrospective analysis of 45,855 initial ECGs obtained between March 1987 and July 2000 that were ordered for usual clinical indications. The 3,104 patients found to be in AF on the initial ECG
Baseline demographics and ECG characteristics
There were a total of 42,751 patients with an initial ECG demonstrating absence of AF. These patients were followed for an average of 5.3 years and received a mean of 3.2 follow-up ECGs. Fifty-three percent of patients received 1 ECG, 15% had 2 ECGs, and 32% had more than 2 ECGs. The period between ECGs was, on average, 3.0 years. During this period, 1,050 (2.4%) patients were found to have AF on a subsequent ECG. Table I presents the baseline demographic information of patients who maintained
Discussion
Atrial fibrillation has been growing at a pace rapid enough to be labeled an epidemic.34 Because the population continues to grow and age, the prevalence of AF and its heavy burden on health care will continue to surge. Novel therapies such as better-tolerated anticoagulants, more selective antiarrhythmics, and catheter interventions are evolving and will make treatment of AF less challenging in the future.
As these therapies for AF become safer and more affordable, screening for AF will gain
References (36)
- et al.
Postoperative arrhythmias after coronary artery and cardiac valvular surgery detected by long-term electrocardiographic monitoring
Am Heart J
(1979) - et al.
Risk factors for atrial fibrillation after coronary artery bypass grafting
Am J Cardiol
(1990) - et al.
Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial
Lancet
(2001) - et al.
P-wave signal-averaged electrocardiogram for predicting atrial arrhythmia after cardiac surgery
Ann Thorac Surg
(2005) - et al.
Signal-averaged P-wave duration and risk of paroxysmal atrial fibrillation in hyperthyroidism
Am J Cardiol
(1996) - et al.
P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion
Int J Cardiol
(2005) - et al.
Long-term prognostic value of p-wave characteristics for the development of atrial fibrillation in subjects aged 55 to 74 years at baseline
Am J Cardiol
(2007) - et al.
A point-score system for the ECG diagnosis of left ventricular hypertrophy
Am Heart J
(1968) - et al.
The normal spatial QRS-T angle of the orthogonal vectorcardiogram
Am Heart J
(1958) - et al.
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study
J Am Coll Cardiol
(2005)